BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37742944)

  • 1. Clinicopathological characteristics and molecular analysis of lymphocyte-rich hepatocellular carcinoma.
    Tsutsui K; Nakayama M; Ogasawara S; Akiba J; Kondo R; Mihara Y; Yano Y; Mizuochi S; Kinjo Y; Murotani K; Yano H
    Hum Pathol; 2023 Nov; 141():43-53. PubMed ID: 37742944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of lymphocyte-rich hepatocellular carcinoma and the prognostic role of tertiary lymphoid structures.
    Ahn B; Ahn HS; Shin J; Jun E; Koh EY; Ryu YM; Kim SY; Sung CO; Shim JH; Hong J; Kim K; Kang HJ
    Liver Int; 2024 May; 44(5):1202-1218. PubMed ID: 38363048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenomic landscape of hepatocellular carcinoma with immune cell stroma and EBV-positive tumor-infiltrating lymphocytes.
    Kang HJ; Oh JH; Chun SM; Kim D; Ryu YM; Hwang HS; Kim SY; An J; Cho EJ; Lee H; Shim JH; Sung CO; Yu E
    J Hepatol; 2019 Jul; 71(1):91-103. PubMed ID: 30930222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration.
    Wada Y; Nakashima O; Kutami R; Yamamoto O; Kojiro M
    Hepatology; 1998 Feb; 27(2):407-14. PubMed ID: 9462638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCL20, a direct-acting pro-angiogenic chemokine induced by hepatitis C virus (HCV): Potential role in HCV-related liver cancer.
    Benkheil M; Van Haele M; Roskams T; Laporte M; Noppen S; Abbasi K; Delang L; Neyts J; Liekens S
    Exp Cell Res; 2018 Nov; 372(2):168-177. PubMed ID: 30287142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between CCL20/CCR6/Th17 axis and vascular invasion and metastasis in patients with primary hepatocellular carcinoma].
    Chang X; Wang L; Zang M; Rong W; Wu Z; Liu L; Du J; Liu J; Wu J; Qu C
    Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):5-10. PubMed ID: 25877311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced expression and clinical significance of CC-chemokine MIP-3 alpha in hepatocellular carcinoma.
    Rubie C; Frick VO; Wagner M; Rau B; Weber C; Kruse B; Kempf K; Tilton B; König J; Schilling M
    Scand J Immunol; 2006 Jun; 63(6):468-77. PubMed ID: 16764701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DEPDC1 drives hepatocellular carcinoma cell proliferation, invasion and angiogenesis by regulating the CCL20/CCR6 signaling pathway.
    Guo W; Li H; Liu H; Ma X; Yang S; Wang Z
    Oncol Rep; 2019 Sep; 42(3):1075-1089. PubMed ID: 31322256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver-infiltrating CD8(+) lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma.
    Ramzan M; Sturm N; Decaens T; Bioulac-Sage P; Bancel B; Merle P; Tran Van Nhieu J; Slama R; Letoublon C; Zarski JP; Jouvin-Marche E; Marche PN; Leroy V
    Liver Int; 2016 Mar; 36(3):434-44. PubMed ID: 26215124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased mRNA expression of chemokines in hepatocellular carcinoma with tumor-infiltrating lymphocytes.
    Hirano S; Iwashita Y; Sasaki A; Kai S; Ohta M; Kitano S
    J Gastroenterol Hepatol; 2007 May; 22(5):690-6. PubMed ID: 17444857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphoepithelioma-like hepatocellular carcinoma: an uncommon variant of hepatocellular carcinoma with favorable outcome.
    Chan AW; Tong JH; Pan Y; Chan SL; Wong GL; Wong VW; Lai PB; To KF
    Am J Surg Pathol; 2015 Mar; 39(3):304-12. PubMed ID: 25675010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCR6
    He H; Wu J; Zang M; Wang W; Chang X; Chen X; Wang R; Wu Z; Wang L; Wang D; Lu F; Sun Z; Qu C
    Am J Cancer Res; 2017; 7(5):1151-1163. PubMed ID: 28560063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-infiltrating, interleukin-33-producing effector-memory CD8(+) T cells in resected hepatocellular carcinoma prolong patient survival.
    Brunner SM; Rubner C; Kesselring R; Martin M; Griesshammer E; Ruemmele P; Stempfl T; Teufel A; Schlitt HJ; Fichtner-Feigl S
    Hepatology; 2015 Jun; 61(6):1957-67. PubMed ID: 25645298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Expression Level of PD1 by Tumor-Infiltrating CD8
    Kim HD; Song GW; Park S; Jung MK; Kim MH; Kang HJ; Yoo C; Yi K; Kim KH; Eo S; Moon DB; Hong SM; Ju YS; Shin EC; Hwang S; Park SH
    Gastroenterology; 2018 Dec; 155(6):1936-1950.e17. PubMed ID: 30145359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung and lymph node metastases from hepatocellular carcinoma: Comparison of pathological aspects.
    Woo HY; Rhee H; Yoo JE; Kim SH; Choi GH; Kim DY; Woo HG; Lee HS; Park YN
    Liver Int; 2022 Jan; 42(1):199-209. PubMed ID: 34490997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer cell-intrinsic STING is associated with CD8 + T-cell infiltration and might serve as a potential immunotherapeutic target in hepatocellular carcinoma.
    Zhang Y; Zhai Q; Feng X; Chen D; Lu Y; Hu J; Xie H; Zhou L; Wu J; Zheng S
    Clin Transl Oncol; 2021 Jul; 23(7):1314-1324. PubMed ID: 33502741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis.
    Chen KJ; Lin SZ; Zhou L; Xie HY; Zhou WH; Taki-Eldin A; Zheng SS
    PLoS One; 2011; 6(9):e24671. PubMed ID: 21935436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cell infiltration and prognosis of human hepatocellular carcinoma.
    Cai XY; Gao Q; Qiu SJ; Ye SL; Wu ZQ; Fan J; Tang ZY
    J Cancer Res Clin Oncol; 2006 May; 132(5):293-301. PubMed ID: 16421755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour epithelial and stromal characteristics of hepatocellular carcinomas with abundant fibrous stroma: fibrolamellar versus scirrhous hepatocellular carcinoma.
    Kim YJ; Rhee H; Yoo JE; Alves VAF; Kim GJ; Kim HM; Herman P; Chagas A; Kim H; Park YN
    Histopathology; 2017 Aug; 71(2):217-226. PubMed ID: 28326574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcomatoid hepatocellular carcinoma is distinct from ordinary hepatocellular carcinoma: Clinicopathologic, transcriptomic and immunologic analyses.
    Morisue R; Kojima M; Suzuki T; Nakatsura T; Ojima H; Watanabe R; Sugimoto M; Kobayashi S; Takahashi S; Konishi M; Ishii G; Gotohda N; Fujiwara T; Ochiai A
    Int J Cancer; 2021 Aug; 149(3):546-560. PubMed ID: 33662146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.